izpis_h1_title_alt

Increased L-selectin on monocytes is linked to the autoantibody profile in systemic sclerosis
ID Brezovec, Neža (Author), ID Perdan-Pirkmajer, Katja (Author), ID Kuret, Tadeja (Author), ID Burja, Blaž (Author), ID Sodin-Šemrl, Snežna (Author), ID Čučnik, Saša (Author), ID Lakota, Katja (Author)

.pdfPDF - Presentation file, Download (1,93 MB)
MD5: 2F0E3261DAE12E548D82FF474D2DFE41
URLURL - Source URL, Visit https://www.mdpi.com/1422-0067/23/4/2233 This link opens in a new window

Abstract
Monocytes are known to be implicated in the pathogenesis of systemic sclerosis (SSc), as they exert prominent migratory, adhesive, and chemotactic properties. The aim of our study was to characterize the surface expression of adhesion/chemotactic molecules (CD62L, CD11b, CCR2, CCR5) on the SSc monocytes and determine correlations with the clinical presentation of SSc. We included 38 SSc patients and 36 healthy age-and sex-matched controls. Isolated monocytes, as well as in vitro serum-treated monocytes, were analyzed by flow cytometry; additionally, soluble CD62L was measured in serum. We found increased soluble CD62L in the SSc serum samples and increased CD62L on the surface of the SSc monocytes in the in the same set of patients. Among samples with determined SSc-specific autoantibodies, the surface CD62L was the lowest in patients positive for anti-PM/Scl autoantibodies and the highest in patients with anti-topoisomerase I autoantibodies (ATA). The treatment of isolated healthy monocytes with ATA-positive SSc serum resulted in increased surface CD62L expression. Moreover, surface CCR5 was reduced on the monocytes from SSc patients with interstitial lung disease but also, along with CCR2, negatively correlated with the use of analgesics/anti-inflammatory drugs and immunosuppressants. In conclusion, increased CD62L on SSc monocytes, particularly in ATA-positive patients, provides new insights into the pathogenesis of SSc and suggests CD62L as a potential therapeutic target.

Language:English
Keywords:systemic sclerosis, monocytes, autoantibodies, adhesion, chemotaxis, CD62L, CCR2, CCR5, CD11b
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:15 str.
Numbering:Vol. 23, iss. 4, art. 2233
PID:20.500.12556/RUL-137285 This link opens in a new window
UDC:61
ISSN on article:1422-0067
DOI:10.3390/ijms23042233 This link opens in a new window
COBISS.SI-ID:98089987 This link opens in a new window
Publication date in RUL:09.06.2022
Views:515
Downloads:82
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:17.02.2022

Secondary language

Language:Slovenian
Keywords:sistemska skleroza, monociti, avtoprotitelesa

Projects

Funder:ARRS - Slovenian Research Agency
Project number:Z3-9261
Name:Raziskovanje mehanizmov, ki povzročajo fibrozo pri sistemski sklerozi

Funder:ARRS - Slovenian Research Agency
Project number:J7-8276
Name:Vpliv protirevmatičnih zdravil na inzulinsko rezistenco in energijsko presnovo v skeletni mišici

Funder:ARRS - Slovenian Research Agency
Project number:P3-0314
Name:Sistemske avtoimunske bolezni

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back